
July 10 (Reuters) - Soleno Therapeutics Inc SLNO.O:
SOLENO THERAPEUTICS ANNOUNCES PROPOSED $200 MILLION PUBLIC OFFERING OF COMMON STOCK
SOLENO THERAPEUTICS INC - PROCEEDS TO FUND VYKAT XR COMMERCIALIZATION FOR PRADER-WILLI SYNDROME
SOLENO THERAPEUTICS INC - GRANTS UNDERWRITERS OPTION FOR $30 MILLION ADDITIONAL SHARES